Beyond ATP: Metabolite networks as regulators of erythroid differentiation.

erythroid differentiation hematopoiesis metabolic therapeutic strategies metabolism pathological erythropoiesis

Journal

Physiology (Bethesda, Md.)
ISSN: 1548-9221
Titre abrégé: Physiology (Bethesda)
Pays: United States
ID NLM: 101208185

Informations de publication

Date de publication:
03 Sep 2024
Historique:
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: aheadofprint

Résumé

Hematopoietic stem cells (HSCs) possess the capacity for self-renewal and the sustained production of all mature blood cell lineages. It has been well established that a metabolic rewiring controls the switch of HSCs from a self-renewal state to a more differentiated state but it is only recently that we have appreciated the importance of metabolic pathways in regulating the commitment of progenitors to distinct hematopoietic lineages. In the context of erythroid differentiation, an extensive network of metabolites - including amino acids, sugars, nucleotides, fatty acids, vitamins, and iron - is required for red blood cell (RBC) maturation. In this review, we will highlight the multi-faceted roles via which metabolites regulate physiological erythropoiesis as well as the effects of metabolic perturbations on erythroid lineage commitment and differentiation. Of note, the erythroid differentiation process is associated with an exceptional breadth of SLC metabolite transporter upregulation. Finally, we will discuss how recent research, revealing the critical impact of metabolic reprogramming in diseases of disordered and ineffective erythropoiesis, has created opportunities for the development of novel metabolic-centered therapeutic strategies.

Identifiants

pubmed: 39226028
doi: 10.1152/physiol.00035.2024
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : HHS | NIH | NCI | Center for Cancer Research (CCR)
ID : ZIA BC 011924
Organisme : Association Nationale de la Recherche et de la Technologie (ANRT)
ID : LABEX GR-Ex)-ANR Avenir-11-LABX-0005-02
Organisme : Association Nationale de la Recherche et de la Technologie (ANRT)
ID : EpiGenMed
Organisme : Spanish Ministry of Science, Innovation, and Universities
ID : Ramon y Cajal program (RYC-2021-033856-I)

Auteurs

Axel Joly (A)

University of Montpellier, Montpellier, France.

Arthur Schott (A)

University of Montpellier, Montpellier, France.

Ira Phadke (I)

National Institutes of Health, Bethesda, MD, United States.

Pedro Gonzalez-Menendez (P)

Universidad de Oviedo, Oviedo, Spain.

Sandrina Kinet (S)

university of Montpellier, Montpellier, France.

Naomi Taylor (N)

Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD, United States.

Classifications MeSH